TY - JOUR
T1 - Population data improves variant interpretation in autosomal dominant polycystic kidney disease
AU - Mallawaarachchi, Amali C.
AU - Furlong, Timothy J.
AU - Shine, John
AU - Harris, Peter C.
AU - Cowley, Mark J.
N1 - Publisher Copyright:
© 2018, American College of Medical Genetics and Genomics.
PY - 2019/6/1
Y1 - 2019/6/1
N2 - Purpose: Autosomal dominant polycystic kidney disease (ADPKD) is a common adult-onset monogenic disorder, with prevalence of 1/1000. Population databases including ExAC have improved pathogenic variant prioritization in many diseases. Due to pseudogene homology of PKD1, the predominant ADPKD disease gene, and the variable disease severity and age of onset, we aimed to investigate the utility of ExAC for variant assessment in ADPKD. Methods: We assessed coverage and variant quality in the ExAC cohort and combined allele frequency and age data from the ExAC database (n = 60,706) with curated variants from 2000 ADPKD pedigrees (ADPKD Mutation Database). Results: Seventy-six percent of PKD1 and PKD2 were sequenced adequately for variant discovery and variant quality was high in ExAC. In ExAC, we identified 25 truncating and 393 previously reported disease-causing variants in PKD1 and PKD2, 6.9-fold higher than expected. Fifty-four different variants, previously classified as disease-causing, were observed in ≥5 participants in ExAC. Conclusion: Our study demonstrates that many previously implicated disease-causing variants are too common, challenging their pathogenicity, or penetrance. The presence of protein-truncating variants in older participants in ExAC demonstrates the complexity of variant classification and highlights need for further study of prevalence and penetrance of this common monogenic disease.
AB - Purpose: Autosomal dominant polycystic kidney disease (ADPKD) is a common adult-onset monogenic disorder, with prevalence of 1/1000. Population databases including ExAC have improved pathogenic variant prioritization in many diseases. Due to pseudogene homology of PKD1, the predominant ADPKD disease gene, and the variable disease severity and age of onset, we aimed to investigate the utility of ExAC for variant assessment in ADPKD. Methods: We assessed coverage and variant quality in the ExAC cohort and combined allele frequency and age data from the ExAC database (n = 60,706) with curated variants from 2000 ADPKD pedigrees (ADPKD Mutation Database). Results: Seventy-six percent of PKD1 and PKD2 were sequenced adequately for variant discovery and variant quality was high in ExAC. In ExAC, we identified 25 truncating and 393 previously reported disease-causing variants in PKD1 and PKD2, 6.9-fold higher than expected. Fifty-four different variants, previously classified as disease-causing, were observed in ≥5 participants in ExAC. Conclusion: Our study demonstrates that many previously implicated disease-causing variants are too common, challenging their pathogenicity, or penetrance. The presence of protein-truncating variants in older participants in ExAC demonstrates the complexity of variant classification and highlights need for further study of prevalence and penetrance of this common monogenic disease.
KW - ADPKD
KW - PKD1
KW - PKD2
KW - exome sequencing
KW - variant interpretation
UR - http://www.scopus.com/inward/record.url?scp=85055982420&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85055982420&partnerID=8YFLogxK
U2 - 10.1038/s41436-018-0324-x
DO - 10.1038/s41436-018-0324-x
M3 - Article
C2 - 30369598
AN - SCOPUS:85055982420
SN - 1098-3600
VL - 21
SP - 1425
EP - 1434
JO - Genetics in Medicine
JF - Genetics in Medicine
IS - 6
ER -